Bicheng Wang
26PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (26)
Sort by Publication Date:
|Dec 18, 2025
Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial.Jing Tang, Yongqiang Yang, Dongen Liu
|Aug 02, 2024
The efficacy and safety of antiangiogenesis tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: A meta-analysis of prospective studies.Ru-Bo Cao, Yao Ge, Wen-Xuan Zhang
|Jan 30, 2024
Lenvatinib Versus Atezolizumab Plus Bevacizumab in the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis of Real-World Studies.Bi-Cheng Wang, Bo-Hua Kuang, Guo-He Lin
|Aug 21, 2023
Novel-fosfamide monotherapy or in combination with doxorubicin versus doxorubicin alone in patients with advanced soft tissue sarcoma: A pooled analysis of randomized clinical trials.Xin-Xiu Liu, Yan-Hong Han, Bo-Hua Kuang
|Jul 28, 2023
An integrated analysis of Sacituzumab govitecan in relapsed or refractory metastatic triple-negative breast cancer.Shao-Xian Cheng, Qiu-Chi Chen, Guo-He Lin
|Nov 18, 2022
A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer.Xin-Xiu Liu, Guo-He Lin, Bi-Cheng Wang
Pageof 5
